Cargando…

Autoimmune rheumatic diseases: One or many diseases?

Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one entity into another, as well as common autoantibod...

Descripción completa

Detalles Bibliográficos
Autor principal: Moutsopoulos, Haralampos M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716565/
https://www.ncbi.nlm.nih.gov/pubmed/35005593
http://dx.doi.org/10.1016/j.jtauto.2021.100129
_version_ 1784624349052928000
author Moutsopoulos, Haralampos M.
author_facet Moutsopoulos, Haralampos M.
author_sort Moutsopoulos, Haralampos M.
collection PubMed
description Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one entity into another, as well as common autoantibody responses, suggest that autoimmune and autoinflammatory disorders may constitute distinct pathophysiologic processes on the basis of a different genetic background. Prognosis and effective therapeutic regimens are mostly based on the clinico-pathologic severity of the involved tissues or organs and not on the disease label.
format Online
Article
Text
id pubmed-8716565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87165652022-01-06 Autoimmune rheumatic diseases: One or many diseases? Moutsopoulos, Haralampos M. J Transl Autoimmun VSI: Autoimmune disorder Until the etiopathogenic factor(s) of autoimmune and autoinflammatory rheumatic disorders will be identified, their classification into entities will continue. However, their similar clinical manifestations, overlapping syndromes, evolution from one entity into another, as well as common autoantibody responses, suggest that autoimmune and autoinflammatory disorders may constitute distinct pathophysiologic processes on the basis of a different genetic background. Prognosis and effective therapeutic regimens are mostly based on the clinico-pathologic severity of the involved tissues or organs and not on the disease label. Elsevier 2021-10-28 /pmc/articles/PMC8716565/ /pubmed/35005593 http://dx.doi.org/10.1016/j.jtauto.2021.100129 Text en © 2021 The Author. Published by Elsevier B.V. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle VSI: Autoimmune disorder
Moutsopoulos, Haralampos M.
Autoimmune rheumatic diseases: One or many diseases?
title Autoimmune rheumatic diseases: One or many diseases?
title_full Autoimmune rheumatic diseases: One or many diseases?
title_fullStr Autoimmune rheumatic diseases: One or many diseases?
title_full_unstemmed Autoimmune rheumatic diseases: One or many diseases?
title_short Autoimmune rheumatic diseases: One or many diseases?
title_sort autoimmune rheumatic diseases: one or many diseases?
topic VSI: Autoimmune disorder
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716565/
https://www.ncbi.nlm.nih.gov/pubmed/35005593
http://dx.doi.org/10.1016/j.jtauto.2021.100129
work_keys_str_mv AT moutsopoulosharalamposm autoimmunerheumaticdiseasesoneormanydiseases